EIA
NVO

Eastover Investment Advisors’s Novo Nordisk NVO Stock Holding History

Eastover Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.07M Buy
84,893
+2,811
+3% +$121K 1.6% 26
2026
Q1 		$3.02M Buy
82,082
+19,629
+31% +$930K 1.29% 27
2025
Q4 		$3.18M Buy
62,453
+2,642
+4% +$135K 1.4% 26
2025
Q3 		$3.32M Buy
+59,811
New +$3.5M 1.44% 27

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Eastover Investment Advisors's NVO Position: Q2 2026 in Review

Eastover Investment Advisors increased its Novo Nordisk (NVO) stake by 3.4% in Q2 2026, buying an estimated $121K and bringing the position to 84,893 shares worth $4.07M. The position accounts for 1.6% of the portfolio, ranked #26.

Eastover Investment Advisors first reported a position in NVO in Q3 2025 and has held it in 4 quarters since. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Eastover Investment Advisors held 84,893 shares of Novo Nordisk worth $4.07M as of Q2 2026.
  • Eastover Investment Advisors bought 2,811 Novo Nordisk shares in Q2 2026, an estimated $121K.
  • Novo Nordisk made up 1.6% of Eastover Investment Advisors's portfolio in Q2 2026, its #26 holding.
  • Eastover Investment Advisors first reported a position in Novo Nordisk in Q3 2025 and has held it in 4 quarters since.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Eastover Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.